Dimethyl fumarate (BG-12, Tecfidera) will start to be available on the NHS in England and Wales from November following final guidance from NICE (National Institute for Health and Care Excellence).
Sativex (nabiximols) has been recommended by the All Wales Medicines Strategy Group (AWMSG) for use within NHS Wales for the treatment of MS-related spasticity.
Swimmer with MS wins 7 medals at the IPC Swimming European Championships.
A recent article in the Irish Times explores the role of language in the diagnosis of life-challenging conditions including multiple sclerosis.
A large study has shown that people with HIV appear to be at a significantly lower risk of developing MS.